“Him coming home … is the magnum opus of this whole situation,” said Keishera Joubert, reflecting on her son Cassian’s incredible journey. In a groundbreaking surgical procedure in Florida, Cassian was born twice, undergoing a partial delivery to save his life.
At just 25 weeks into his mother’s pregnancy, doctors diagnosed Cassian with congenital high airway obstruction syndrome (Chaos), a condition affecting about one in every 50,000 births. The surgery involved partially delivering him while he remained attached to his mother’s placenta—a rare and complex procedure.
After spending four months in the neonatal intensive care unit, Cassian finally came home weighing only 3 pounds (1.4 kg). His arrival marked a moment of joy for his parents, Keishera and Greg Joubert.
Key facts about Cassian’s case:
- Cassian’s condition was discovered at 19 weeks into the pregnancy.
- The surgery took place when Keishera was 25 weeks pregnant.
- Cassian spent four months in the NICU before going home.
As they prepare for Cassian’s first birthday, Keishera shared plans for celebrations: “We’re planning just a small party for his birthday, [the] anniversary of his surgery that saved his life – and then, of course, for his ‘birth’ birthday, we’re going to have another … bash for him there to celebrate a whole year.” This sentiment captures the profound relief and gratitude felt by the Jouberts.
Meanwhile, another issue has surfaced regarding infant health. The A2 Milk Company recently recalled over 63,000 containers of its A2 Platinum Premium Infant Formula due to contamination with cereulide—a toxin that can cause foodborne illness, particularly in infants. This recall affects three specific batches with batch numbers 2210269454, 2210321712, and 2210324609.
No confirmed illnesses have been reported related to this recall, but it raises concerns among parents about safety in infant nutrition during such critical times.
The Jouberts’ story does not only highlight medical advancements but also underscores the challenges many families face when dealing with congenital conditions. Cassian’s case is expected to be presented at an international medical conference in Japan this October—an opportunity to share insights from this extraordinary medical journey.
